Clinical effects of debulking surgery combined with neoadjuvant chemotherapy in treating ovarian cancer and its influence on tumor markers and immune function.

MLA

Huijuan Yan, et al. “Clinical Effects of Debulking Surgery Combined with Neoadjuvant Chemotherapy in Treating Ovarian Cancer and Its Influence on Tumor Markers and Immune Function.” Pakistan Journal of Medical Sciences, vol. 40, no. 11, Dec. 2024, pp. 2475–79. EBSCOhost, https://doi.org/10.12669/pjms.40.11.9337.

APA

Huijuan Yan, Weiwei Wang, Shengchao Wang, Chunmei Yan, & Li Zhu. (2024). Clinical effects of debulking surgery combined with neoadjuvant chemotherapy in treating ovarian cancer and its influence on tumor markers and immune function. Pakistan Journal of Medical Sciences, 40(11), 2475–2479. https://doi.org/10.12669/pjms.40.11.9337

Chicago

Huijuan Yan, Weiwei Wang, Shengchao Wang, Chunmei Yan, and Li Zhu. 2024. “Clinical Effects of Debulking Surgery Combined with Neoadjuvant Chemotherapy in Treating Ovarian Cancer and Its Influence on Tumor Markers and Immune Function.” Pakistan Journal of Medical Sciences 40 (11): 2475–79. doi:10.12669/pjms.40.11.9337.